Stock Price
35.84
Daily Change
-0.20 -0.56%
Monthly
-13.34%
Yearly
-1.24%
Q1 Forecast
35.13

Qiagen NV reported $0.52 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.46 0.49 May/04 2026
FY2025Q4 Dec/2025 0.50 0.52 0.59 Feb/04 2026
FY2025Q3 Sep/2025 0.53 0.5 0.54 Nov/04 2025
FY2025Q2 Jun/2025 0.60 0.53 0.51 Aug/05 2025
FY2025Q1 Mar/2025 0.49 0.47 0.43 May/07 2025




Eps Change Date
Akebia Therapeutics USD 0.03 0.13 Mar/2025
Alaunos Therapeutics USD -0.53 0.07 Sep/2025
argenx SE USD 6.8 2.36 Dec/2025
Avita Medical AUD -0.38 0 Dec/2025
Dianthus Therapeutics USD -0.97 0.09 Sep/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
IQVIA Holdings USD 3.42 0.42 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Organon & Co USD 0.63 0.38 Dec/2025
Qiagen NV USD 0.52 0.01 Dec/2025
Revvity USD 1.7 0.52 Dec/2025
Tectonic Therapeutic USD -1.02 0.05 Sep/2025
Viatris USD 0.57 0.1 Dec/2025
Xeris Pharmaceuticals USD 0 0.02 Sep/2025